Enterohemorrhagic escherichia coli O26:H11/H-: A New virulent clone emerges in Europe

Clinical Infectious Diseases

Volumn 56, Issue 10, 2013, Pages 1373-1381

  Bielaszewska, Martina ^a   Mellmann, Alexander ^a   Bletz, Stefan ^a   Zhang, Wenlan ^a   Köck, Robin ^a   Kossow, Annelene ^a   Prager, Rita ^b   Fruth, Angelika ^b   Orth Höller, Dorothea ^c   Marejková, Monika ^d   Morabito, Stefano ^e   Caprioli, Alfredo ^e   Piérard, Denis ^f   Smith, Geraldine ^g   Jenkins, Claire ^g   Čurová, Katarína ^h   Karch, Helge ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^d NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^e ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^f UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^g CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^h P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

enterohemorrhagic Escherichia coli O26; hemolytic uremic syndrome; new clone; Shiga toxin

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BLOODY DIARRHEA; CHILD; CONTROLLED STUDY; DIARRHEA; DISEASE ASSOCIATION; ENTEROHEMORRHAGIC ESCHERICHIA COLI; EUROPE; FEMALE; GENE STRUCTURE; GENOTYPE; HEMOLYTIC UREMIC SYNDROME; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTILOCUS SEQUENCE TYPING; PHYLOGENY; PLASMID; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SCHOOL CHILD;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; EUROPE; FEMALE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; PHYLOGENY; PLASMIDS; POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84876167891     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit055     Document Type: Article

References (39)

1. Tarr PI, Gordon CA, Chandler WL. Shiga toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005; 365:1073-86.
2. Siegler RL. Postdiarrheal Shiga toxin-mediated hemolytic uremic syndrome. JAMA 2003; 290:1379-81.
3. Gerber A, Karch H, Allerberger F, Verweyen HM, Zimmerhackl LB. Clinical course and the role of Shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study. J Infect Dis 2002; 186:493-500.
4. Tozzi E, Caprioli A, Minelli F, et al. Shiga toxin-producing Escherichia coli infections associated with hemolytic uremic syndrome, Italy, 1988-2000. Emerg Infect Dis 2003; 9:106-8.
5. Ethelberg S, Olsen KE, Scheutz F, et al. Virulence factors for hemolytic uremic syndrome, Denmark. Emerg Infect Dis 2004; 10:842-7.
6. Espié E, Grimont F, Mariani-Kurkdjian P, et al. Surveillance of hemolytic uremic syndrome in children less than 15 years of age, a system to monitor O157 and non-O157 Shiga toxin-producing Escherichia coli infections in France, 1996-2006. Pediatr Infect Dis J 2008; 27:595-601.
7. Mellmann A, Bielaszewska M, Köck R, et al. Analysis of collection of hemolytic uremic syndrome-associated enterohemorrhagic Escherichia coli. Emerg Infect Dis 2008; 14:1287-90.
8. Käppeli U, Hächler H, Giezendanner N, Beutin L, Stephan R. Human infections with non-O157 Shiga toxin-producing Escherichia coli, Switzerland, 2000-2009. Emerg Infect Dis 2011; 17:180-5.
9. Buvens G, De Gheldre Y, Dediste A, et al. Incidence and virulence determinants of verocytotoxin-producing Escherichia coli infections in the Brussels-Capital Region, Belgium, in 2008-2010. J Clin Microbiol 2012; 50:1336-45.
10. Zimmerhackl LB, Rosales A, Hofer J, et al. Enterohemorrhagic Escherichia coli O26:H11-associated hemolytic uremic syndrome: bacteriology and clinical presentation. Semin Thromb Hemost 2010; 36:586-93.
11. Brooks JT, Sowers EG, Wells JG, et al. Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002. J Infect Dis 2005; 192:1422-29.
12. Jelacic JK, Damrow T, Chen GS, et al. Shiga toxin-producing Escherichia coli in Montana: bacterial genotypes and clinical profiles. J Infect Dis 2003; 188:719-29.
13. Hedican EB, Medus C, Besser JM, et al. Characteristics of O157 versus non-O157 Shiga toxin-producing Escherichia coli infections in Minnesota, 2000-2006. Clin Infect Dis 2009; 49:358-64.
14. Rivas M, Miliwebsky E, Chinen I, et al. Characterization and epidemiologic subtyping of Shiga toxin-producing Escherichia coli strains isolated from hemolytic uremic syndrome and diarrhea cases in Argentina. Foodborne Pathog Dis 2006; 3:88-96.
15. Hiroi M, Takahashi N, Harada T, et al. Serotype, Shiga toxin (Stx) type, and antimicrobial resistance of Stx-producing Escherichia coli isolated from humans in Shizuoka Prefecture, Japan (2003-2007). Jpn J Infect Dis 2012; 65:198-202.
16. Elliott EJ, Robins-Browne RM, O'Loughlin EV, et al. Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features. Arch Dis Child 2001; 85:125-31.
17. Pollock KG, Bhojani S, Beattie TJ, et al. Highly virulent Escherichia coli O26, Scotland. Emerg Infect Dis 2011; 17:1777-9.
18. Zieg J, Dusek J, Marejkova M, et al. Fatal case of diarrhea-associated hemolytic uremic syndrome with severe neurologic involvement. Pediatr Int 2012; 54:166-7.
19. Rosales A, Hofer J, Zimmerhackl LB, et al. Need for long-term followup in enterohemorrhagic Escherichia coli-associated hemolytic uremic syndrome due to late-emerging sequelae. Clin Infect Dis 2012; 54:1413-21.
20. Scheutz F, Teel LD, Beutin L, et al. Multicenter evaluation of a sequence-based protocol for subtyping Shiga toxins and standardizing Stx nomenclature. J Clin Microbiol 2012; 50:2951-63.
21. Ethelberg S, Smith B, Torpdahl M, et al. Outbreak of non-O157 Shiga toxin-producing Escherichia coli infection from consumption of beef sausage. Clin Infect Dis 2009; 48:e78-81.
22. Zhang WL, Bielaszewska M, Liesegang A, et al. Molecular characteristics and epidemiological significance of Shiga toxin-producing Escherichia coli O26 strains. J Clin Microbiol 2000; 38:2134-40.
23. Allerberger F, Friedrich AW, Grif K, et al. Hemolytic-uremic syndrome associated with enterohemorrhagic Escherichia coli O26:H infection and consumption of unpasteurized cow's milk. Int J Infect Dis 2003; 7:42-5.
24. Sobieszczañska BM, Gryko R, Malek CW. Isolation of verotoxigenic strains of Escherichia coli O26 in Poland. Clin Microbiol Infect 2000; 6:227-9.
25. Chase-Topping ME, Rosser T, Allison LJ, et al. Pathogenic potential to humans of bovine Escherichia coli O26, Scotland. Emerg Infect Dis 2012; 18:439-48.
26. Bielaszewska M, Friedrich AW, Aldick T, Schürk-Bulgrin R, Karch H. Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome. Clin Infect Dis 2006; 43:1160-7.
27. Ribot EM, Fair MA, Gautom R, et al. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog Dis 2006; 3:59-67.
28. European Committee on Antimicrobial Susceptibility Testing (EUCAST). EUCAST MIC and Zone diameter breakpoint tables, 2012. Available at: http://www.eucast.org/antimicrobial-susceptibility-testing/breakpoints/. Accessed 22 October 2012.
29. European Committee on Antimicrobial Susceptibility Testing (EUCAST). Antimicrobial susceptibility testing EUCAST disk diffusion method, 2012. Available at: http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST-files/Disk- test-documents/Manual-v-2.1-EUCAST-Disk-Test.pdf. Accessed 22 October 2012.
30. European Food Safety Authority, European Centre for Disease Prevention and Control. The European Union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2009. EFSA Journal 2011; 9:2090. Available at: http://www.efsa.europa. eu/efsajournal. Accessed 15 January 2013.
31. European Food Safety Authority, European Centre for Disease Prevention and Control. The European Union summary report on trends and sources of zoonoses, zoonotic agents and food-borne outbreaks in 2010. EFSA Journal 2012; 10:2597. Available at: http://www.efsa. europa.eu/efsajournal. Accessed 15 January 2013.
32. Registrato Italiano della Sindrome Emolitico-Uremica. Situazione epidemiologica della SEU in Italia. Available at: http://www.iss.it/seu/ital/ cont.php?id=15&lang=1&tipo=15. Accessed 18 January 2013 .
33. Bielaszewska M, Prager R, Köck R, et al. Shiga toxin gene loss and transfer in vitro and in vivo during enterohemorrhagic Escherichia coli O26 infection in humans. Appl Environ Microbiol 2007; 73:3144-50.
34. Mellmann A, Bielaszewska M, Karch H. Intrahost genome alterations in enterohemorrhagic Escherichia coli. Gastroenterology 2009; 136: 1925-38.
35. Frank C, Werber D, Cramer JP, et al. Epidemic profile of Shiga-toxinproducing Escherichia coli O104:H4 outbreak in Germany. N Engl J Med 2011; 365:1771-80.
36. Hickey CA, Beattie TJ, Cowieson J, et al. Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome. Arch Pediatr Adolesc Med 2011; 165: 884-9.
37. Wong CS, Mooney JC, Brandt JR, et al. Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis. Clin Infect Dis 2012; 55:33-41.
38. Geue L, Klare S, Schnick C, Mintel B, Meyer K, Conraths FJ. Analysis of the clonal relationship of serotype O26:H11 enterohemorrhagic Escherichia coli isolates from cattle. Appl Environ Microbiol 2009; 75:6947-53.
39. Blanco M, Blanco JE, Mora A, et al. Serotypes, virulence genes, and intimin types of Shiga toxin (verotoxin)-producing Escherichia coli isolates from cattle in Spain and identification of a new intimin variant gene (eae-ζ). J Clin Microbiol 2004; 42:645-51.